Literature DB >> 12114248

vCJD: the epidemic that never was. New variant Creutzfeldt-Jakob disease: the critique that never was.

R G Will, R S G Knight, H J T Ward, J W Ironside.   

Abstract

Mesh：

Year:  2002        PMID： 12114248      PMCID： PMC1123598     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Extent of misclassification of death from Creutzfeldt-Jakob disease in England 1979-96: retrospective examination of clinical records.

Authors:  A Majeed; P Lehmann; L Kirby; R Knight; M Coleman
Journal:  BMJ       Date:  2000-01-15

2.  Antibodies inhibit prion propagation and clear cell cultures of prion infectivity.

Authors:  D Peretz; R A Williamson; K Kaneko; J Vergara; E Leclerc; G Schmitt-Ulms; I R Mehlhorn; G Legname; M R Wormald; P M Rudd; R A Dwek; D R Burton; S B Prusiner
Journal:  Nature       Date:  2001-08-16       Impact factor: 49.962

Review 3.  New variant Creutzfeldt-Jakob disease: the epidemic that never was.

Authors:  G A Venters
Journal:  BMJ       Date:  2001-10-13

4.  BSE and variant Creutzfeldt-Jakob disease: never say never.

Authors:  Herbert Budka; Dominique Dormont; Hans Kretzschmar; Maurizio Pocchiari; Cornelia van Duijn
Journal:  Acta Neuropathol       Date:  2002-04-13       Impact factor: 17.088

5.  Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.

Authors:  G J Raymond; J Hope; D A Kocisko; S A Priola; L D Raymond; A Bossers; J Ironside; R G Will; S G Chen; R B Petersen; P Gambetti; R Rubenstein; M A Smits; P T Lansbury; B Caughey
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

6.  Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent.

Authors:  M E Bruce; R G Will; J W Ironside; I McConnell; D Drummond; A Suttie; L McCardle; A Chree; J Hope; C Birkett; S Cousens; H Fraser; C J Bostock
Journal:  Nature       Date:  1997-10-02       Impact factor: 49.962

7.  Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD.

Authors:  R G Will; A Alperovitch; S Poser; M Pocchiari; A Hofman; E Mitrova; R de Silva; M D'Alessandro; N Delasnerie-Laupretre; I Zerr; C van Duijn
Journal:  Ann Neurol       Date:  1998-06       Impact factor: 10.422

Review 8.  The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system.

Authors:  E P Richardson; C L Masters
Journal:  Brain Pathol       Date:  1995-01       Impact factor: 6.508

9.  Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host.

Authors:  C A McLean; J W Ironside; M P Alpers; P W Brown; L Cervenakova; R M Anderson; C L Masters
Journal:  Brain Pathol       Date:  1998-07       Impact factor: 6.508

10.  More on BSE/vCJD.

Authors:  Gordon T Stewart
Journal:  J R Soc Med       Date:  2002-02       Impact factor: 18.000
View more
  3 in total

1.  Why aren't we more ahead? The risk of variant Creutzfeldt-Jakob disease from eating bovine spongiform encephalopathy-infected foods: still undetermined.

Authors:  Miquel Porta; Alfredo Morabia
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  The First Evaluation of Proteinase K-Resistant Prion Protein (PrPSc) in Korean Appendix Specimens.

Authors:  Sae-Young Won; Yong-Chan Kim; Yu-Ni Lee; Chan-Gyun Park; Woo-Young Kim; Byung-Hoon Jeong
Journal:  Medicina (Kaunas)       Date:  2022-07-18       Impact factor: 2.948

3.  The new variant of the Creutzfeldt-Jakob disease accounts for no relative increase of the Creutzfeldt-Jakob disease mortality rate in the United Kingdom; this fits ill with the new variant being the consequence of consumption of food infected with the agent of Bovine Spongiform Encephalopathy.

Authors:  Ivan Laprevotte; Alain Hénaut
Journal:  BMC Public Health       Date:  2003-08-06       Impact factor: 3.295
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.